SK Bioscience Co. on Wednesday reported its second-quarter net loss of 11.4 billion won (US$8.3 million), remaining in the red compared with a year ago. The company said in a regulatory filing that it continued to post an operating loss of 19.9 billion won for the April-June period, compared with a loss of 35.3 billion won a year earlier. Revenue rose 1.1 percent to 26.8 billion won. Source: Yonhap News Agency
Recent Posts
Foreign Fund Outflows Contribute to Taiwan Dollar Depreciation
October 27, 2026
Taiwan Issues Sea Warning as Typhoon Champi Approaches
October 22, 2026
Taiwan Braces for Impact as Typhoon Champi Approaches
October 22, 2026
Alishan Recreation Area and Railway to Close Due to Typhoon Champi
October 22, 2026